QR-koda

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents

Abstract Background This systematic review and meta-analysis evaluates the safety and efficacy of emerging prostate-specific membrane antigen (PSMA) radioligand therapy (RLT) agents used beyond [¹⁷⁷Lu]Lu-PSMA in metastatic castration-resistant prostate cancer (mCRPC). Methods Systematic searches of...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Ahmed Saad Abdlkadir, Dhuha Al-Adhami, Serin Moghrabi, Mike Machaba Sathekge, Michael Kreissl, Enrique Estrada-Lobato, Hongcheng Shi, Akram Al-Ibraheem
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: BMC 2026-03-01
Ráidu:BMC Cancer
Fáttát:
PSMA RLT
Prostate cancer
[²²⁵Ac]Ac-PSMA
[¹⁶¹Tb]Tb-PSMA
[¹³¹I]PSMA
Tandem therapy
Liŋkkat:https://doi.org/10.1186/s12885-026-15900-y
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid